- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01602133
Assessment of Ultrasound-guided Inserted Peripheral Intravenous Catheter (ECLIPSE)
October 24, 2012 updated by: Prodimed SAS
A Clinical Assessment of an Ultrasound-guided Inserted Peripheral Intravenous Catheter
Evaluate the safety and efficacy of an an ultrasound-guided inserted peripheral intravenous catheter during a period of seven days.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
29
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: pascal meyer, MD
- Email: pas.meyer@yahoo.fr
Study Locations
-
-
-
Corbeil-essonnes, France, 91 100
- Recruiting
- Centre Hospitalier Sud Francilien
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Hospitalized patients with need of an intravenous therapy on peripheral line
- Unsuccessful attempts at establishing a peripheral intravenous line by nurse
- Age over 18 YO
- Written informed consent obtained
Exclusion Criteria:
- pregnant woman
- local contra-indication for venous puncture
- unconscious patient
- need of intravenous therapy requiring central line
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: one intervention arm
|
Ultrasound imaging of the arm is performed.
If a suitable vein is identified, a percutaneous puncture is performed under ultrasound guidance.
Then, an intravenous catheter is inserted according Seldinger method.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
length of use of the catheter measured in number of days
Time Frame: seven days
|
seven days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
adverse event during the period of use of the catheter
Time Frame: seven days
|
extravasation and/or catheter removal before the end of the treatment and/or local complications (bleeding, neurologic trouble, venous thrombosis..)
|
seven days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Pascal Meyer, MD, Centre Hospitalier Sud Francilien- Corbeil- France
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Anticipated)
June 1, 2014
Study Completion (Anticipated)
June 1, 2014
Study Registration Dates
First Submitted
May 17, 2012
First Submitted That Met QC Criteria
May 17, 2012
First Posted (Estimate)
May 18, 2012
Study Record Updates
Last Update Posted (Estimate)
October 25, 2012
Last Update Submitted That Met QC Criteria
October 24, 2012
Last Verified
October 1, 2012
More Information
Terms related to this study
Other Study ID Numbers
- 2011-A01570-41
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Venous Puncture
-
Delray Medical CenterFlorida Atlantic UniversityCompletedVenous PunctureUnited States
-
University of Health Sciences LahoreNot yet recruiting
-
Second Affiliated Hospital, School of Medicine,...RecruitingEducation, Medical | Venous Puncture | Students, MedicalChina
-
Hôpital NOVORecruiting
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...CompletedVenous Puncture | Vascular Access DevicesItaly
-
Region Jönköping CountyRegion ÖstergötlandRecruitingPain | Cancer | Patient Satisfaction | Venous PunctureSweden
-
University Hospital, GenevaCompletedPain | Anxiety | Venous PunctureSwitzerland
-
Instituto de Investigación Sanitaria AragónCompletedEmergencies | Nursing Caries | Venous PunctureSpain
-
Aalborg University HospitalAalborg UniversityCompletedPain, Acute | Venous Puncture | Children, Adult
-
Dartmouth-Hitchcock Medical CenterTerminated
Clinical Trials on peripheral venous puncture
-
University Children's Hospital, ZurichInstitute of Medical Microbiology, University of Zurich, Zurich, SwitzerlandNot yet recruiting
-
Centre Hospitalier Universitaire, AmiensCompletedGeriatric | VenipunctureFrance
-
Assiut UniversityCompleted
-
University Hospital of PatrasCompletedNeovascular Age-related Macular DegenerationGreece
-
National Council of Scientific and Technical Research...Merck Sharp & Dohme LLCCompletedInhibition of Platelet Aggregation by Incretins
-
Instituto de fertilidad humana, InSerUniversity of Alabama at Birmingham; Colmédicos S.A.S.; ABAD LaboratorioRecruitingEndocrine System Diseases | Polycystic Ovary Syndrome | HyperandrogenismColombia
-
National Taiwan University HospitalUnknownOvarian CancerTaiwan
-
UMC UtrechtHoffmann-La RocheCompletedHIV Infections | Hepatitis CNetherlands
-
National Taiwan University HospitalCompleted
-
Assistance Publique - Hôpitaux de ParisRecruiting